Mexico Salud
  • HOME
  • BACK TO MBP

Interview of the Week: Biotechnology Designed to Meet Local Needs

On July 4, 2018 By Alicia Arizpe
Felix Scott, Director General and Country Chair of Sanofi, spoke to Mexico Health Review on the company’s pipeline and how can it change Mexico’s healthcare. Q: How is Sanofi and its biotechnology addressing Mexico’s main health concerns? A: We are redefining treatment for cardiovascular diseases. Sanofi was the first company in Mexico to launch a [...]
Read Full Article →

Mexico to Get First Dengue Fever Vaccine in the World

On September 12, 2016 By Sophie Murten
The first vaccine against the dangerous dengue fever was released in Mexico today after over 20 years of research, announced Sanofi Pasteur, the pharmaceutical firm involved on its development. The medicine, which received COFEPRIS approval in late 2015, is a tetravalent vaccine, meaning it is efficient against all four dengue virus serotypes. It [...]
Read Full Article →

Mexico First Country to Approve Dengue Vaccine

On December 11, 2015 By Ricardo Ibarra
After 17 years of research, Sanofi Pasteur is ready to launch Dengvaxia®, the first anti-dengue vaccine aimed at reducing infections by 25% and mortality by 50% in 128 countries in 2020. Mexico was one of the first countries to participate in clinical trials for this vaccine, which involved 40,000 people in 15 countries, and is [...]
Read Full Article →
  • HOME
  • BACK TO MBP